1. Home
  2. BIAF vs PRZO Comparison

BIAF vs PRZO Comparison

Compare BIAF & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • PRZO
  • Stock Information
  • Founded
  • BIAF 2014
  • PRZO 2014
  • Country
  • BIAF United States
  • PRZO Israel
  • Employees
  • BIAF N/A
  • PRZO N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PRZO
  • Sector
  • BIAF Health Care
  • PRZO
  • Exchange
  • BIAF Nasdaq
  • PRZO Nasdaq
  • Market Cap
  • BIAF 12.2M
  • PRZO 13.7M
  • IPO Year
  • BIAF 2022
  • PRZO 2023
  • Fundamental
  • Price
  • BIAF $0.21
  • PRZO $0.88
  • Analyst Decision
  • BIAF Hold
  • PRZO
  • Analyst Count
  • BIAF 1
  • PRZO 0
  • Target Price
  • BIAF N/A
  • PRZO N/A
  • AVG Volume (30 Days)
  • BIAF 799.6K
  • PRZO 1.2M
  • Earning Date
  • BIAF 05-23-2025
  • PRZO 03-21-2025
  • Dividend Yield
  • BIAF N/A
  • PRZO N/A
  • EPS Growth
  • BIAF N/A
  • PRZO N/A
  • EPS
  • BIAF N/A
  • PRZO N/A
  • Revenue
  • BIAF $9,362,022.00
  • PRZO $932,154.00
  • Revenue This Year
  • BIAF N/A
  • PRZO N/A
  • Revenue Next Year
  • BIAF $19.99
  • PRZO N/A
  • P/E Ratio
  • BIAF N/A
  • PRZO N/A
  • Revenue Growth
  • BIAF 269.68
  • PRZO 50.22
  • 52 Week Low
  • BIAF $0.16
  • PRZO $0.49
  • 52 Week High
  • BIAF $2.99
  • PRZO $3.16
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 32.86
  • PRZO 55.88
  • Support Level
  • BIAF $0.19
  • PRZO $0.80
  • Resistance Level
  • BIAF $0.24
  • PRZO $0.94
  • Average True Range (ATR)
  • BIAF 0.04
  • PRZO 0.10
  • MACD
  • BIAF -0.02
  • PRZO 0.01
  • Stochastic Oscillator
  • BIAF 13.80
  • PRZO 43.23

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About PRZO ParaZero Technologies Ltd.

ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the comapany applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.

Share on Social Networks: